Related Experiment Videos
Validity of in vitro testing.
1Bureau of Drug Research, Health Protection Branch, Ottawa, Ontario, Canada.
Drug Metabolism Reviews
|January 1, 1990
Summary
Toxicity studies for nitroimidazole drug residues require accessible residue amounts. The Salmonella assay is proposed for toxicity evaluation, with in vivo studies suggested for target tissues to resolve genotoxicity contradictions.
Area of Science:
- Pharmacology
- Toxicology
- Genetics
Background:
- Nitroimidazole drugs present a genotoxicity testing challenge.
- In vitro microbial assays show mutagenicity, but mammalian cell assays do not.
- Tumorigenic effects in rodents at high doses may not be genotoxic.
Purpose of the Study:
- To propose methods for evaluating the toxicity of bound nitroimidazole drug residues.
- To address the apparent contradiction in the genotoxicity of nitroimidazole drugs.
- To suggest a comprehensive toxicity screening strategy.
Main Methods:
- Utilizing the Salmonella assay for evaluating bound residue toxicity.
- Investigating in vivo effects in target tissues like gastrointestinal epithelial cells.
- Considering nuclear aberration and sister chromatid exchange assays.
Main Results:
- The availability of bound residues dictates the scope of toxicity studies.
- Nitroimidazole drugs are potent in vitro mutagens but not in mammalian cells in vitro or in vivo.
- Discrepancies suggest non-genotoxic mechanisms for tumorigenicity.
Conclusions:
- Reassessing in vivo genotoxicity of nitroimidazole drugs is crucial.
- A battery of complementary in vitro and in vivo tests is recommended for toxicity screening.
- This approach ensures detection of meaningful biological activity for further investigation.